These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

706 related items for PubMed ID: 20134314

  • 1. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer.
    Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, Kerin MJ.
    Ann Surg; 2010 Mar; 251(3):499-505. PubMed ID: 20134314
    [Abstract] [Full Text] [Related]

  • 2. Analysis of serum genome-wide microRNAs for breast cancer detection.
    Wu Q, Wang C, Lu Z, Guo L, Ge Q.
    Clin Chim Acta; 2012 Jul 11; 413(13-14):1058-65. PubMed ID: 22387599
    [Abstract] [Full Text] [Related]

  • 3. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform.
    Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM, Cohn DE.
    Gynecol Oncol; 2009 Jan 11; 112(1):55-9. PubMed ID: 18954897
    [Abstract] [Full Text] [Related]

  • 4. Circulating microRNA-1 as a potential novel biomarker for acute myocardial infarction.
    Ai J, Zhang R, Li Y, Pu J, Lu Y, Jiao J, Li K, Yu B, Li Z, Wang R, Wang L, Li Q, Wang N, Shan H, Li Z, Yang B.
    Biochem Biophys Res Commun; 2010 Jan 01; 391(1):73-7. PubMed ID: 19896465
    [Abstract] [Full Text] [Related]

  • 5. Serum microRNA profiling and breast cancer risk: the use of miR-484/191 as endogenous controls.
    Hu Z, Dong J, Wang LE, Ma H, Liu J, Zhao Y, Tang J, Chen X, Dai J, Wei Q, Zhang C, Shen H.
    Carcinogenesis; 2012 Apr 01; 33(4):828-34. PubMed ID: 22298638
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus.
    Wang H, Peng W, Ouyang X, Li W, Dai Y.
    Transl Res; 2012 Sep 01; 160(3):198-206. PubMed ID: 22683424
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Circulating miR-34a levels are reduced in colorectal cancer.
    Nugent M, Miller N, Kerin MJ.
    J Surg Oncol; 2012 Dec 01; 106(8):947-52. PubMed ID: 22648208
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MicroRNA expression and its implications for the diagnosis and therapeutic strategies of breast cancer.
    Shi M, Guo N.
    Cancer Treat Rev; 2009 Jun 01; 35(4):328-34. PubMed ID: 19171434
    [Abstract] [Full Text] [Related]

  • 18. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines.
    Leivonen SK, Mäkelä R, Ostling P, Kohonen P, Haapa-Paananen S, Kleivi K, Enerly E, Aakula A, Hellström K, Sahlberg N, Kristensen VN, Børresen-Dale AL, Saviranta P, Perälä M, Kallioniemi O.
    Oncogene; 2009 Nov 05; 28(44):3926-36. PubMed ID: 19684618
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 36.